Efficacy News and Research

RSS
Oral salmon calcitonin using absorption-enhancing Eligen Technology holds promise for osteoarthritis

Oral salmon calcitonin using absorption-enhancing Eligen Technology holds promise for osteoarthritis

Angiochem reports Phase 1/2 efficacy study results of ANG1005 for treating brain cancer

Angiochem reports Phase 1/2 efficacy study results of ANG1005 for treating brain cancer

AstraZeneca's CRESTOR approved for treating pediatric patients with HeFH

AstraZeneca's CRESTOR approved for treating pediatric patients with HeFH

Angiochem announces results of Phase 1 /2 clinical trials of ANG1005

Angiochem announces results of Phase 1 /2 clinical trials of ANG1005

CONFIRMS trial demonstrates efficacy of ULORIC for treating hyperuricemia in patients with gout

CONFIRMS trial demonstrates efficacy of ULORIC for treating hyperuricemia in patients with gout

Rituxan's sBLA receives a Complete Response from the FDA

Rituxan's sBLA receives a Complete Response from the FDA

Ethics in biomedical research: One-year grant from NIH to develop interactive educational software

Ethics in biomedical research: One-year grant from NIH to develop interactive educational software

DKC establishes link between genetic mutation affecting telomerase function and human disease

DKC establishes link between genetic mutation affecting telomerase function and human disease

Cardium Therapeutics reports positive findings from Excellarate Phase 1/2 clinical study

Cardium Therapeutics reports positive findings from Excellarate Phase 1/2 clinical study

Mallinckrodt TaperGuard and TaperGuard Evac endotracheal tubes launched by Covidien

Mallinckrodt TaperGuard and TaperGuard Evac endotracheal tubes launched by Covidien

Biogen Idec and Biovitrum to conduct rFIXFc clinical trial in hemophilia B patients

Biogen Idec and Biovitrum to conduct rFIXFc clinical trial in hemophilia B patients

PHARMACIA & UPJOHN COMPANY to pay the largest criminal fine ever imposed in the U.S.

PHARMACIA & UPJOHN COMPANY to pay the largest criminal fine ever imposed in the U.S.

Innovative tool for providing patient-centered care for diabetics

Innovative tool for providing patient-centered care for diabetics

GlaxoSmithKline receives FDA approval for cervical cancer vaccine

GlaxoSmithKline receives FDA approval for cervical cancer vaccine

HealthScape Consumer to analyze patient and consumer data

HealthScape Consumer to analyze patient and consumer data

China's SFDA approves Celsion’s global Phase III ThermoDox HEAT trial for treating liver cancer

China's SFDA approves Celsion’s global Phase III ThermoDox HEAT trial for treating liver cancer

Access Pharmaceuticals' update on its European commercial launch of Mugard

Access Pharmaceuticals' update on its European commercial launch of Mugard

Inspire to present its denufosol tetrasodium cystic fibrosis program data at the 23rd NACFC

Inspire to present its denufosol tetrasodium cystic fibrosis program data at the 23rd NACFC

Positive results from Protalix BioTherapeutics Phase III UPLYSO clinical trial

Positive results from Protalix BioTherapeutics Phase III UPLYSO clinical trial

Negative symptoms represent an attractive target for drug development

Negative symptoms represent an attractive target for drug development

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.